Free Trial

Cineplex (TSE:CGX) Price Target Raised to C$12.00

Cineplex logo with Communication Services background

Cineplex (TSE:CGX - Free Report) had its price target upped by Canaccord Genuity Group from C$11.50 to C$12.00 in a research note issued to investors on Thursday, BayStreet.CA reports.

A number of other equities research analysts also recently issued reports on the stock. Desjardins upped their price target on shares of Cineplex from C$52.00 to C$53.00 and gave the company a "buy" rating in a research note on Thursday, August 1st. Scotiabank upped their target price on shares of Cineplex from C$10.00 to C$12.00 and gave the company an "outperform" rating in a research report on Monday, August 12th. TD Securities lifted their price target on Cineplex from C$14.00 to C$16.00 and gave the stock a "buy" rating in a research report on Friday, August 16th. Finally, Royal Bank of Canada reduced their price objective on Cineplex from C$14.00 to C$13.00 in a research note on Wednesday, July 24th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of C$18.71.

View Our Latest Stock Report on CGX

Cineplex Price Performance

CGX stock traded up C$0.03 during mid-day trading on Thursday, hitting C$10.45. The company had a trading volume of 198,646 shares, compared to its average volume of 351,971. The company has a market capitalization of C$665.46 million, a price-to-earnings ratio of -9.33, a P/E/G ratio of 0.30 and a beta of 2.74. The company has a 50-day moving average price of C$10.52 and a 200 day moving average price of C$9.00. The company has a quick ratio of 0.22, a current ratio of 0.36 and a debt-to-equity ratio of 30,533.69. Cineplex has a 12-month low of C$7.10 and a 12-month high of C$11.16.

Cineplex (TSE:CGX - Get Free Report) last posted its earnings results on Friday, August 9th. The company reported C($0.33) EPS for the quarter. The company had revenue of C$277.34 million during the quarter, compared to the consensus estimate of C$283.90 million. On average, research analysts anticipate that Cineplex will post 1.0754912 earnings per share for the current year.

About Cineplex

(Get Free Report)

Cineplex Inc, together with its subsidiaries, operates as an entertainment and media company in Canada and internationally. It operates through three segments: Film Entertainment and Content, Media, and Location-Based Entertainment. The company engages in theatre exhibitions and food service activities; and provision of alternative programming service comprising international film programming, as well as content offered under the Event Cinema brand, including The Metropolitan Opera, sporting events, concerts, and dedicated event screens.

Read More

Analyst Recommendations for Cineplex (TSE:CGX)

Should you invest $1,000 in Cineplex right now?

Before you consider Cineplex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cineplex wasn't on the list.

While Cineplex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines